Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Celebrating a year of immunotherapy/cell and gene therapy in Blood Advances. | Blood Adv | 2024 | 39718780 | PubTator, text mining | PubMed |
| Combination Treatment of Resistant Acute Promyelocytic Leukemia Cells with Arsenic Trioxide and Anti-Apoptotic Gene Inhibitors. | Pharmaceuticals (Basel) | 2024 | 39598439 | PubTator, text mining | PubMed |
| The mononuclear phagocyte system obscures the accurate diagnosis of infected joint replacements. | J Transl Med | 2024 | 39563367 | PubTator, text mining | PubMed |
| IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy. | Cell Rep Med | 2024 | 39536753 | PubTator, text mining | PubMed |
| Lethal Disseminated Mucorales Infection With Positive Blood Cultures With Purpura Fulminans Complicating Hemophagocytic Lymphohistiocytosis After Chimeric Antigen Receptor T-Cell Therapy. | Open Forum Infect Dis | 2024 | 39507882 | PubTator, text mining | PubMed |
| Construction of a Prognostic Model for Mitochondria and Macrophage Polarization Correlation in Glioma Based on Single-Cell and Transcriptome Sequencing. | CNS Neurosci Ther | 2024 | 39491527 | PubTator, text mining | PubMed |
| The future of cellular therapy for the treatment of renal cell carcinoma. | Expert Opin Biol Ther | 2024 | 39485013 | PubTator, text mining | PubMed |
| Significance of CD70, VEGF, and CD90 Immunohistochemical Expression in Colorectal Cancer. | Asian Pac J Cancer Prev | 2024 | 39471037 | PubTator, text mining | PubMed |
| CD70 is a potential prognostic marker and significantly regulates cellular function in diffuse large B-cell lymphoma. | PLoS One | 2024 | 39446784 | PubTator, text mining | PubMed |
| A Comprehensive Study on the Prognostic Value and Clinicopathological Significance of Different Immune Checkpoints in Patients With Colorectal Cancer: A Systematic Review and Meta-Analysis. | Curr Ther Res Clin Exp | 2024 | 39434898 | PubTator, text mining | PubMed |
| Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC. | Front Oncol | 2024 | 39411143 | PubTator, text mining | PubMed |
| Integrated multi-omics profiling reveals the ZZZ3/CD70 axis is a super-enhancer-driven regulator of diffuse large B-cell lymphoma cell-natural killer cell interactions. | Exp Biol Med (Maywood) | 2024 | 39376717 | PubTator, text mining | PubMed |
| Cancer immunotherapy by γδ T cells. | Science | 2024 | 39361750 | PubTator, text mining | PubMed |
| Sequence variants underlying severe combined immunodeficiency and leukocyte adhesion deficiency type 1 in six consanguineous families. | Immunogenetics | 2024 | 39287664 | PubTator, text mining | PubMed |
| Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia. | J Hematol Oncol | 2024 | 39285441 | PubTator, text mining | PubMed |
| Tannic acid elicits differential gene regulation in prostate cancer apoptosis. | Acta Pharm | 2024 | 39279521 | PubTator, text mining | PubMed |
| Pediatric Plasmablastic Lymphoma in the Setting of CD70 Deficiency. | J Pediatr Hematol Oncol | 2024 | 39262383 | PubTator, text mining | PubMed |
| Different estimation techniques and data analysis for constant-partially accelerated life tests for power half-logistic distribution. | Sci Rep | 2024 | 39242750 | PubTator, text mining | PubMed |
| The dual role of POSTN in maintaining glioblastoma stem cells and the immunosuppressive phenotype of microglia in glioblastoma. | J Exp Clin Cancer Res | 2024 | 39227950 | PubTator, text mining | PubMed |
| Development of bioassay platforms for biopharmaceuticals using Jurkat-CAR cells by AICD. | J Pharm Biomed Anal | 2024 | 39197208 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=13